Hamaoka, N <br/><br/>
Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.  [electronic resource] 

 -  British journal of anaesthesia  Apr 2001 
 - 540-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0912 
<br/><br/><label>Standard No.: </label>10.1093/bja/86.4.540  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anesthetics, Intravenous--metabolism<br/>Anti-Anxiety Agents--metabolism<br/>Antibodies, Monoclonal--immunology<br/>Aryl Hydrocarbon Hydroxylases<br/>Cytochrome P-450 CYP1A2<br/>Cytochrome P-450 CYP2B6<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--immunology<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Hydroxylation<br/>Microsomes, Liver--metabolism<br/>Midazolam--metabolism<br/>Orphenadrine--pharmacology<br/>Oxidoreductases, N-Demethylating--antagonists & inhibitors<br/>Steroid 16-alpha-Hydroxylase<br/>Steroid Hydroxylases--antagonists & inhibitors<br/>Troleandomycin--pharmacology